Metals have been used as antimicrobial agents since antiquity, but throughout most of history their modes of action have remained unclear. Recent studies indicate that different metals cause discrete and distinct types of injuries to microbial cells as a result of oxidative stress, protein dysfunction or membrane damage. Here, we describe the chemical and toxicological principles that underlie the antimicrobial activity of metals and discuss the preferences of metal atoms for specific microbial targets. Interdisciplinary research is advancing not only our understanding of metal toxicity but also the design of metal-based compounds for use as antimicrobial agents and alternatives to antibiotics.

Antimicrobial activity of metals: mechanisms, molecular targets and applications

Synthetic organic chemists enjoy the luxury of having a large collection of reliable reactions at their disposal for preparing small molecules, mesoscopic structures, and polymers. Coordination chemists, on the other hand, are faced with the fact that transition metal chemistry, when normalized for the number of transition metals, has relatively few high-yielding reactions, when compared to the chemistry of carbon, for preparing even small molecule structures. This lack of control is manifested, in large part, in the weak metal-ligand interactions found in coordination complexes as compared with the strong covalent bonds in organic compounds. Weak bonding often translates into many reaction pathways that are not substantially different from an energetic point of view, and therefore, results in poor selectivity. As a result, many coordination chemists in recent years have come to the realization that it may be easier and more productive to develop straightforward and reliable routes to mesoscopic supramolecular structures by capitalizing on the modest collection of high-yielding reactions in coordination chemistry, the directional bonding afforded by metal centers, and strategies aimed at taking advantage of the weak metal bonds found in coordination complexes. Three emerging synthetic strategies, the symmetry-interaction, directional-bonding, and weak-link synthetic approaches, all use metal centers as structural building blocks to rationally assemble molecular components into supramolecular metallocyclophanes. These three approaches are discussed herein, and the fundamental principles underlying each as well as their capabilities are compared and contrasted.

Strategies for the Construction of Supramolecular Compounds through Coordination Chemistry

In this review we intend to provide a relatively comprehensive summary of the work of supramolecular hydrogelators after 2004 and to put emphasis particularly on the applications of supramolecular hydrogels/hydrogelators as molecular biomaterials. After a brief introduction of methods for generating supramolecular hydrogels, we discuss supramolecular hydrogelators on the basis of their categories, such as small organic molecules, coordination complexes, peptides, nucleobases, and saccharides. Following molecular design, we focus on various potential applications of supramolecular hydrogels as molecular biomaterials, classified by their applications in cell cultures, tissue engineering, cell behavior, imaging, and unique applications of hydrogelators. Particularly, we discuss the applications of supramolecular hydrogelators after they form supramolecular assemblies but prior to reaching the critical gelation concentration because this subject is less explored but may hold equally great promise for helping ...

Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials

Artificial Molecular Rotors

https://www.pnas.org/content/pnas/90/5/1635.full.pdf

Supramolecular chemistry.

Leishmaniasis is a disease that ranges in severity from skin lesions to serious disfigurement and fatal systemic infection. WHO estimates that the disease results in 2 million new cases a year, threatens 350 million people in 88 countries and that there are 12 million people currently infected worldwide. Current treatment is based on chemotherapy, which relies on a handful of drugs with serious limitations such as high cost, toxicity, difficult route of administration and lack of efficacy in endemic areas. Pentavalent antimonials have been the mainstay of antileishmanial therapy for over 70 years with second line drugs, Amphotericin B and Pentamidine, used in case of antimonial failure. Since the introduction of miltefosine at the beginning of this century, no new antileishmanial compounds have been approved for human treatment. Leishmaniasis is considered one of a few parasitic diseases likely to be controllable by vaccination. However, to date no such vaccine is available despite substantial efforts by many laboratories. The development of a safe, effective and affordable antileishmanial vaccine is a critical global public-health priority. This review outlines the current status of vaccine development and looks at the currently available chemotherapy as well as examples of drugs in development and different approaches to antileishmanial drug discovery and identification of novel antiparasitic compounds.

Leishmaniasis: current treatment and prospects for new drugs and vaccines.

Towards a Structural Understanding of the Anti‐Ulcer and Anti‐Gastritis Drug Bismuth Subsalicylate

Many first-line treatments for neglected tropical diseases identified by the World Health Organization (WHO) are limited by one or more of the following: the development of drug resistance, toxicity, and side effects, lack of selectivity, narrow therapeutic indices, route of administration, and bioavailability. As such, there is an urgent need to develop viable alternatives to overcome these limitations. The following review provides an overview of all existing metal complexes studied and evaluates the status of these complexes on the respective disease of choice.

Metal Compounds against Neglected Tropical Diseases

Reaction of LaCl3 and dibenzoylmethane (Ph2acacH) in methanol with an excess of triethylamine resulted in the unexpected formation of a dodecanuclear hydroxo-bridged La cluster templated by CO32− and phenylglyoxylate (Phgly), as determined by X-ray crystallography.

Philip C. Andrews

Papers

Leishmaniasis: current treatment and prospects for new drugs and vaccines.

Towards a Structural Understanding of the Anti‐Ulcer and Anti‐Gastritis Drug Bismuth Subsalicylate

Metal Compounds against Neglected Tropical Diseases

Templated assembly of a µ6-CO32− dodecanuclear lanthanum dibenzoylmethanide hydroxido cluster with concomitant formation of phenylglyoxylate

Synthesis, structure, and deoxyribonucleic acid sequencing with a universal nucleoside : 1-(2'-deoxy-beta -d-ribofuranosyl)-3-nitropyrrole